June 07, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Automated insulin delivery system lowers HbA1c in patients with type 2 diabetes
NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time in range at 13 weeks, researchers reported at the American Diabetes Association Scientific Sessions. As Healio previously reported, the system (twiist, Sequel) received FDA clearance in 2024 for treatment of patients with type 1 diabetes aged 6
851 words~4 min read
